(2-Methyl-1,3-benzothiazol-5-yl)boronic acid → HCID 86720138, compound
Reaction equation
[CH3:1][O:2][C:3](=[O:26])[CH2:4][C@H:5]1[C:9]2[CH:10]=[CH:11][C:12]([O:14][C@H:15]3[C:23]4[C:18](=[C:19]([OH:25])[CH:20]=[CH:21][C:22]=4[F:24])[CH2:17][CH2:16]3)=[CH:13][C:8]=2[O:7][CH2:6]1.[CH3:27][C:28]1[S:29][C:30]2[CH:36]=[CH:35][C:34](B(O)O)=[CH:33][C:31]=2[N:32]=1>>[CH3:1][O:2][C:3](=[O:26])[CH2:4][C@H:5]1[C:9]2[CH:10]=[CH:11][C:12]([O:14][C@H:15]3[C:23]4[C:18](=[C:19]([O:25][C:34]5[CH:35]=[CH:36][C:30]6[S:29][C:28]([CH3:27])=[N:32][C:31]=6[CH:33]=5)[CH:20]=[CH:21][C:22]=4[F:24])[CH2:17][CH2:16]3)=[CH:13][C:8]=2[O:7][CH2:6]1Participants
3
Procedure
The title compound is prepared from {(S)-6-[(R)-7-fluoro-4-hydroxy-indan-1-yloxy]-2,3-dihydro-benzofuran-3-yl}-acetic acid methyl ester and 2-methyl-benzothiazole-5-boronic acid following a procedure analogous to that described for Intermediate 6. LC (method 10): tR=0.91 min; Mass spectrum (ESI+): m/z=506 [M+H]+.
Sources & evidence
- ORD record
- ord-ffb1da29c81d4a4eac68ddb83194ddea
- Source dataset
- uspto-grants-2014_08
- Patent number
- US08815864B2
Reaction notes
Loading…